Trial intelligence / Profile preview

CD-NP in Acute Decompensated Heart Failure

NCT00839007Phase 2Completed

Sponsor
Nile Therapeutics
Start
Jun 2009
Primary completion
Jun 2010
Countries
3
01

Overview

A Phase 2 trial of cenderitide in heart failure (HF), sponsored by Nile Therapeutics. Started Jun 2009; status: completed.

02

Drugs

cenderitide
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00839007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00839007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call